Clinical Trial Update: The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating Negr1's role in neuroplasticity for major depressive disorder and bipolar depression, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Affective Disorder
• Major Depressive Disorder

Drugs mentioned

• Negr1

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Major Depressive Disorder, Bipolar Affective Disorder, Currently Depressed, Moderate | Phase 4 | Status: UNKNOWN